Anna French

Director at Entact Bio

Capital raised by Entact Bio

$10.0M+$10.0M latest round

1 Form D filing · first filed Jan 2026 · Watertown, MA

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2021
30D INTEREST: —

Career

1 company on file · founded 2021

Entact BioBiotech · Watertown, MAsince 2021

Director

Listed on Entact Bio's Form D filings

Company filings

via EDGAR · Form D for Entact Bio1

DateCompanyFormAmountRole on filing

Jan 8, 2026Entact BioForm D+$10.0M—

Form DJan 8, 2026 · Entact Bio+$10.0Mnot a signer

Overview

Last filing Jan 8, 2026

Anna French is on file as Director at Entact Bio in Watertown, MA. Entact Bio has 1 Form D filing on record, $10.0M raised in total.

Teammates

Entact Bio · 1

Victoria RichonChief Executive Officer and Director of the IssuerSigner

Products

Entact Bio · 1

Encompass platformDrug discovery platform

A discovery and optimization platform for ENTAC medicines - bifunctional small molecules that bring a target protein together with a deubiquitylase so the DUB's natural activity enhances that protein's function. The platform systematically tests DUB-substrate combinations to inform rational ENTAC design.